alfuzosin has been researched along with deamino arginine vasopressin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hjalmas, K; Jünemann, KP; Kramer, G; Madersbacher, H; Marschall-Kehrel, AD; Mürtz, G | 1 |
1 review(s) available for alfuzosin and deamino arginine vasopressin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for alfuzosin and deamino arginine vasopressin
Article | Year |
---|---|
[A suggested treatment algorithm in nocturnal enuresis with emphasis on partial responders].
Topics: Adolescent; Algorithms; Behavior Therapy; Benzilates; Biofeedback, Psychology; Child; Child, Preschool; Combined Modality Therapy; Deamino Arginine Vasopressin; Enuresis; Female; Follow-Up Studies; Humans; Male; Outcome and Process Assessment, Health Care; Psychotherapy; Quinazolines; Recurrence; Retreatment; Treatment Failure; Urodynamics | 2004 |